About MAPS Public Benefit Corporation (MAPS PBC):
MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, psychedelic therapist training programs, and in the future - sales of prescription psychedelics. We prioritize patient and public benefit above profits. Founded in 2014, MAPS PBC is a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS) a 501(c)(3) nonprofit. More information about the organization is available at mapspublicbenefit.com.
MAPS PBC is committed to the evolution of psychedelic healing modalities. We are building a diverse and inclusive workplace where we learn from each other. We value transparency, autonomy, experimentation, and kind, direct feedback. We welcome applicants who thrive in the midst of a growing organization that values science and healing.
MAPS PBC advances equity and inclusion in the workplace by providing equal employment opportunity to support a work environment free from discrimination on the basis of race, religious creed, color, national origin, ancestry, physical disability, mental disability, medical condition, genetic information, marital status, sex, gender, gender identity, gender expression, age, sexual orientation, military and veteran status, arrest or conviction record, and any other basis prohibited by law. The organization also provides reasonable accommodations for qualified applicants and employees with disabilities. This equal employment opportunity policy applies to all aspects of employment, including recruitment, selection, advancement, training, problem resolution, and separation from employment. Through this policy, MAPS PBC strives to establish and maintain an equitable and accessible work environment that is supportive and free from discrimination.
MAPS PBC is seeking an innovative mission-aligned professional with experience in late stage drug development and patient access to develop and lead the new Commercial and Patient Access department within MAPS PBC. The Phase 3 program for MDMA-assisted psychotherapy for PTSD has an NDA targeted for 2022, this is a first in class drug.
Reporting directly to the CEO of MAPS PBC, the Senior Director, Head of Commercialization and Patient Access has broad responsibility for strategic and tactical leadership and execution for all areas within the realm of commercialization including:
The first initiative is to develop the commercial plan and supporting infrastructure for MDMA-assisted psychotherapy for people who suffer from PTSD followed by plans for other indications within Central Nervous System disorders. The Senior Director will have broad responsibility for developing the public and private payer interface and providing internal direction of health economic projects. Suitable candidates will have strong leadership skills and be able to work well in a fast-paced environment, provide strategic plans and build and manage a team. This person will be adept at organizing and managing information virtually using required project management systems.
As we are primarily a virtual team, this is a remote position. The current leadership team is primarily on the West Coast. This position requires frequent phone and internet video meetings and virtual management of the department.
Hours: Full time, exempt, salaried position. Must be available during normal business hours for a California-based company.
Summary of Responsibility: Recruit, hire, lead, and develop the commercialization team across commercial functions. Broad Responsibility for:
Go to Market Strategy and Partner Relations
Manufacturing Partnerships, Supply Chain Distribution and Logistics
Safety, REMS, Pharmacovigilance
Marketing, Patient Access, Pricing, Reimbursement and Managed Care
FLSA Status: Exempt / Salaried
Compensation: Salary available upon request. Includes full benefits
Your application was submitted successfully.